2-Days In-Person Seminar

Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)

David L Chesney
San Diego,CA
Jun 20 - Jun 21 , 2019

Starting at

$2399


Jun 20 - Jun 21 , 2019
Buy Now

Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a product ready for market approval in the coming months. Most such companies are small, and may not have deep expertise in QA and GMP compliance, relying on their partners to cover those areas. Companies who outsource the majority of operations through the use of Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and Contract Laboratories, however, remain responsible for the quality and compliance status of the products they send to the clinic or to the marketplace.

In this two day workshop conference you will learn the requirements and expectations of major health care regulators that are applicable to "virtual" companies. You will learn how to diagnose your company's needs based on which GMP and GCP-governed operations you retain and which you outsource; what the current expectations and best industry practices are for selecting, qualifying and monitoring your contractors to ensure they are meeting your requirements; and how to build a quality system framework that is not excessive for your current needs, but has the structure and integration to "grow with you" as the scope your operations change in the coming months and years.

You will also learn best practices for managing a regulatory inspection, with emphasis on FDA, EMA and Health Canada, but applicable to most other major agencies as well.

Learning Objectives:

Participants in this seminar will:

  • Understand the GMP and GCP requirements all virtual companies must meet regardless of the extent of their outsourcing operations
  • Understand how to select, qualify and monitor CMOs, CROs and Contract Laboratories
  • Learn the elements to include in a quality agreement (also known as a technical agreement)
  • Learn how to determine which GMP or GCP requirements apply to you, depending on the things you do internally and those you outsource
  • Understand your obligations under the law for products you release to the clinic or the marketplace
  • Appreciate the importance of maintaining data integrity
  • Learn how to effectively manage a health regulatory inspection:
    • Inspection logistics
    • Responding effectively to document requests and questions from inspectors
    • Managing the inspection exit discussion
    • How to write an effective response to inspection observations
    • How to find applicable inspection references and procedures of the FDA, EMA and Health Canada

Who will Benefit:

This course is designed for those charged with managing Quality Assurance and Regulatory Affairs for companies in the development or commercial phase of growth who either release investigational drugs to clinical trial sites or send commercial products to the market, but rely to a great extent on the use of Contract Manufacturers and/or Contract Laboratories. The following personnel will benefit from the course:

  • Senior quality managers in manufacturing QA/GMP or clinical quality areas
  • Quality professionals
  • Regulatory professionals
  • Clinical Operations
  • Compliance professionals
  • Quality auditors – GMP and GCP
  • Document control specialists
DAY 01(8:30 AM - 4:30 PM)
  • 08.30 AM - 09.00 AM: Registration
  • 09.00 AM: Session Start
  • Introductions and participant expectations for the program
  • Fundamentals of Good Manufacturing Practice
    • What is GMP?
    • Purpose of GMP
    • Basis in law: US, Europe, Canada
    • Elements that apply to all virtual companies
    • Elements that depend on how operations are conducted: How to tell what applies to your company
  • Data Integrity: What it is and why it is important to GMP
  • Fundamentals of Good Clinical Practice (GCP)
    • What is GCP?
    • Purpose of GCP
    • Basis in law: US, Europe, Canada
    • Elements that apply to all virtual companies
    • Elements that depend on how operations are conducted: How to tell what applies to your company
  • Regulatory and business risks: The case for compliance
  • Virtual company organizational structure and responsibility for QA/GMP/GCP
  • Virtual company quality system structure and management
    • Policies, procedures, documentation management
    • Metrics and management review considerations
  • Selection, qualification and monitoring of contractors
    • Initial due diligence – public information sources to gage compliance
    • Qualification of vendors
    • Quality agreements – determining and documenting responsibilities for GMP
    • Vendor audit program
  • Day One Q&A and recap of progress meeting stated course expectations
DAY 02(8:30 AM - 4:30 PM)
  • Regulatory Inspections
    • Purpose of an inspection
    • Reasons for inspections
    • Inspections at virtual company headquarters locations – purpose and scope
    • Inspections at CMOs and Contract Labs
    • GMP inspections versus Preapproval inspections – FDA
    • GCP inspections of sponsors of clinical trials
    • EMA inspections – contrast with FDA
    • Health Canada inspections
  • Logistics for managing inspections at your location
    • Information sources about inspections on agency web sites: What you need and how to find it easily
    • Preparation for inspections
    • Overall process – ready room support
    • Receiving and hosting the inspectors
    • Providing documents
    • Answering questions
    • Interpersonal dos and don’ts for interacting with inspectors
    • Managing the exit discussion at the conclusion of the inspection
  • Inspections at your contract organizations
    • Making sure your CMO and contract lab are “PAI ready”
    • Training employees to assure inspection readiness – pitfalls to make sure you avoid
    • Conducting mock inspections effectively
  • Post-inspection communications with the inspecting agency
    • How to write an effective response
    • Common mistakes to avoid
    • Following up to ensure the response is satisfactory
    • When to request a meeting, and if granted, how best to handle it
  • Enforcement considerations
    • FDA enforcement process – domestic and ex-US
    • EMA enforcement
    • Health Canada
  • Final Q&A, discussion, and conclusion
  • 4:30 PM: Adjourn
Seminar (Price/Register)
Jun 20 - Jun 21 , 2019 (2 Days) San Diego,CA

Single attendee


Seminar Fee Includes:
Lunch
AM-PM Tea/Coffee
Seminar Material
Attendance Certificate
$100 Gift Cert for next seminar

Other Registration Option
  1. Download the Order Form
  2. Fill this form with attendee details & payment details
  3. Fax your PO to 1-888-883-7697 or,
  4. Email it to cs@compliance.world

Payment Mode

By Check -

Pay your check issued from the payee to "Redstone Learning Inc." (Our Parent Company) and mail the check to –
Compliance.world (Redstone Learning Inc.)
1180 Avenue of the Americas,
8th Floor, New York,
NY 10036

  Media Partners

If you wish to partner with us for this event

please contact us: partner or
call us: 1-866-978-0800

Media Partner Benefits

  • Logo and company data on the event website.
  • Logo on the conference material distributed during the conference.
  • Media Partner’s brochure distributed along with conference material.
  • Logo on all the mailings before and after the event.
  • 10% discount to media partner's subscribers.

Media Partner to do

  • Banner (min 728x90 or 468x60) on the Media Partner website.
  • Insertion of the event in the event calendar, both printed and/or online.
  • Announcement article of the conference on the Magazine and/or Website.
  • Dedicated email blast to all subscribers of Media Partner.
  • Article on the Magazine and/or Website after the conference.

  Sponsors

If you wish to partner with us for this event

please contact us: sponsor@compliance.world or
call us: 1-866-978-0800
Speaker: David L Chesney, Principal and General Manager, DL Chesney Consulting, L

David L. Chesney is the Principal and General Manager of DL Chesney Consulting, LLC.

His career includes 23 years with the FDA and over 21 years in GMP and GCP consulting worldwide. In his consulting practice, Mr. Chesney helps clients prevent quality and compliance problems through proactive assessment and planning, and when necessary, with remediation planning and health regulatory authority communications.

Until recently, he served as Vice President, Strategic Compliance Services for PAREXEL Consulting, a business unit of PAREXEL International LLC. Prior to joining PAREXEL Consulting in 1995, Mr. Chesney served 23 years with the FDA, where he advanced from Investigator to Supervisory Investigator and Director, Investigations Branch, working in the Boston, Seattle and Philadelphia District Offices. In 1991, he was appointed the District Director, FDA San Francisco District Office, where he served until joining PAREXEL in 1995. For 19 years, he led the Strategic Compliance Consulting group, and also personally provided regulatory enforcement related consulting services to the pharmaceutical, medical device and biologics industries, plus technical assistance to legal counsel in FDA regulatory matters. Mr. Chesney has a bachelor's degree and postgraduate credits in biology from California State University, Northridge and San Diego, and received a Certificate in Health Care Compliance from Seton Hall University School of Law.


Follow us

Toll Free

1-866-978-0800

Fax

1-888-883-7697